pDCs are increased in HCQ-treated patients. pDCs (A) and IFNα-secreting pDCs (percentage; B) in HIV-infected INR patients at baseline (□), after 6 months (ms) of HCQ treatment (), and 2 months after HCQ interruption (■). Mean values, SE, and P values are indicated.